Inside Precision Medicine June 7, 2023
The post-COVID rise of telemedicine has spawned a unique trial that will give more patients access to targeted therapies for pancreatic cancer, but from the comfort of their home. An entirely telehealth-based cancer clinical trial is being launched at The Ohio State University Comprehensive Cancer Center (OSUCCC).
“This is a game changer for cancer clinical trials, and more importantly, patients,” said Sameek Roychowdhury, MD, PhD, a medical oncologist with OSUCCC and principal investigator of the new study.
He added that, “Traveling for specialized cancer treatment is often cost-prohibitive for patients experiencing cancer—particularly for rare but aggressive types like pancreatic cancer, where clinical trials can represent the most up-to-date and targeted treatment for advanced disease.”
Today's Sponsors
Today's Sponsor